Genetic and Molecular Aspects of Hypertension

Circulation Research

Volumn 116, Issue 6, 2015, Pages 937-959

  Padmanabhan, Sandosh ^a   Caulfield, Mark ^b   Dominiczak, Anna F ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

blood pressure; exome; genome wide association study; hypertension; natriuretic peptide, brain; uromodulin

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; GLUCOCORTICOID; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; MINERALOCORTICOID; SODIUM CHLORIDE; SODIUM POTASSIUM CHLORIDE COTRANSPORTER 2; SODIUM INTAKE;

APPARENT MINERALOCORTICOID EXCESS SYNDROME; BLOOD PRESSURE REGULATION; EXOME; FAMILIAL DISEASE; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HERITABILITY; HUMAN; HYPERTENSION; LIDDLE SYNDROME; MANAGED CARE; MOLECULAR BIOLOGY; MONOGENIC DISORDER; NEXT GENERATION SEQUENCING; NONHUMAN; PARAGANGLIOMA; PHEOCHROMOCYTOMA; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PSEUDOHYPOALDOSTERONISM; REVIEW; SENSITIVITY ANALYSIS; SODIUM RETENTION; ADRENAL TUMOR; ADRENERGIC SYSTEM; ADVERSE EFFECTS; BARTTER SYNDROME; BIOLOGICAL MODEL; BLOOD PRESSURE; DNA MICROARRAY; FAMILIAL CANCER; FEMALE; GENETICS; HYPERALDOSTERONISM; HYPOTENSION; KIDNEY DISEASE; MALE; MATERNAL HYPERTENSION; MUTATION; PATHOPHYSIOLOGY; PHARMACOKINETICS; PHYSIOLOGY; PREGNANCY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SODIUM INTAKE;

ADRENAL GLAND NEOPLASMS; BARTTER SYNDROME; BLOOD PRESSURE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GLUCOCORTICOIDS; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; HYPERTENSION, PREGNANCY-INDUCED; HYPOTENSION; KIDNEY DISEASES; MALE; MINERALOCORTICOIDS; MODELS, CARDIOVASCULAR; MUTATION; NEOPLASTIC SYNDROMES, HEREDITARY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARAGANGLIOMA; PHEOCHROMOCYTOMA; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; RENIN-ANGIOTENSIN SYSTEM; SODIUM, DIETARY; SYMPATHETIC NERVOUS SYSTEM;

EID: 84930148099     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.303647     Document Type: Review

References (90)

1. Wakerlin GE. From Bright toward light: the story of hypertension research. Circ Res 1962;11:131-136.
2. Guyton AC, Coleman TG, Granger HJ. Circulation: overall regulation. Annu Rev Physiol. 1972;34:13-46. doi: 10.1146/annurev. ph.34.030172.000305.
3. Frohlich ED, Dustan HP, Bumpus FM. Irvine H. Page: 1901-1991. The celebration of a leader. Hypertension. 1991;18:443-445.
4. Pickering GW. The genetic factor in essential hypertension. Ann Intern Med 1955;43:457-464.
5. Padmanabhan S, Newton-Cheh C, Dominiczak AF. Genetic basis of blood pressure and hypertension. Trends Genet. 2012;28:397-408. doi: 10.1016/j.tig.2012.04.001.
6. Bochud M, Bovet P, Elston RC, Paccaud F, Falconnet C, Maillard M, Shamlaye C, Burnier M. High heritability of ambulatory blood pressure in families of East African descent. Hypertension. 2005;45:445-450. doi: 10.1161/01.HYP.0000156538.59873.86.
7. Havlik RJ, Garrison RJ, Feinleib M, Kannel WB, Castelli WP, McNamara PM. Blood pressure aggregation in families. Am J Epidemiol. 1979;110:304-312.
8. Hottenga JJ, Boomsma DI, Kupper N, Posthuma D, Snieder H, Willemsen G, de Geus EJ. Heritability and stability of resting blood pressure. Twin Res Hum Genet. 2005;8:499-508. doi: 10.1375/183242705774310123.
9. Kupper N, Willemsen G, Riese H, Posthuma D, Boomsma DI, de Geus EJ. Heritability of daytime ambulatory blood pressure in an extended twin design. Hypertension. 2005;45:80-85. doi: 10.1161/01. HYP.0000149952.84391.54.
10. Snieder H, Harshfield GA, Treiber FA. Heritability of blood pressure and hemodynamics in African- and European-American youth. Hypertension. 2003;41:1196-1201. doi: 10.1161/01.HYP.0000072269.19820.0D.
11. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell. 2001;104:545-556.
12. Rossi GP, Bernini G, Caliumi C, et al.; PAPY Study Investigators. A prospective study of the prevalence of primary aldosteronism in 1, 125 hypertensive patients. J Am Coll Cardiol. 2006;48:2293-2300. doi: 10.1016/j. jacc.2006.07.059.
13. Sinclair AM, Isles CG, Brown I, Cameron H, Murray GD, Robertson JW. Secondary hypertension in a blood pressure clinic. Arch Intern Med. 1987;147:1289-1293.
14. Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res. 2004;27:193-202.
15. Yorgun H, Kabakçi G, Canpolat U, Aytemir K, Fatihoʇlu G, Karakulak UN, Kaya EB, Şahiner L, Tokgözoʇlu L, Oto A. Frequency and predictors of renal artery stenosis in hypertensive patients undergoing coronary angiography. Angiology. 2013;64:385-390. doi: 10.1177/0003319712451900.
16. Leoncini G, Viazzi F, Rosei EA, Ambrosioni E, Costa FV, Leonetti G, Pessina AC, Trimarco B, Volpe M, Deferrari G, Pontremoli R. Chronic kidney disease in hypertension under specialist care: the I-DEMAND study. J Hypertens. 2010;28:156-162. doi: 10.1097/HJH.0b013e328332038c.
17. Lawes CM, Vander Hoorn S, Rodgers A; International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371:1513-1518. doi: 10.1016/S0140-6736(08)60655-8.
18. Newton-Cheh C, Johnson T, Gateva V, et al; Wellcome Trust Case Control Consortium. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet. 2009;41:666-676. doi: 10.1038/ ng.361.
19. Levy D, Ehret GB, Rice K, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet. 2009;41:677-687. doi: 10.1038/ ng.384.
20. Kato N, Takeuchi F, Tabara Y, et al. Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians. Nat Genet. 2011;43:531-538. doi: 10.1038/ ng.834.
21. Ehret GB, Munroe PB, Rice KM et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011;478:103-109.
22. Padmanabhan S, Melander O, Johnson T, et al; Global BPgen Consortium. Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension. PLoS Genet. 2010;6:e1001177. doi: 10.1371/journal.pgen.1001177.
23. Johnson T, Gaunt TR, Newhouse SJ, et al; Cardiogenics Consortium; Global BPgen Consortium. Blood pressure loci identified with a genecentric array. Am J Hum Genet. 2011;89:688-700. doi: 10.1016/j. ajhg.2011.10.013.
24. Tragante V, Barnes MR, Ganesh SK, et al. Gene-centric meta-analysis in 87, 736 individuals of European ancestry identifies multiple bloodpressure- related loci. Am J Hum Genet. 2014;94:349-360. doi: 10.1016/j. ajhg.2013.12.016.
25. Ganesh SK, Tragante V, Guo W, et al; CARDIOGRAM, METASTROKE; LifeLines Cohort Study. Loci influencing blood pressure identified using a cardiovascular gene-centric array. Hum Mol Genet. 2013;22:1663-1678. doi: 10.1093/hmg/dds555.
26. Wain LV, Verwoert GC, O'Reilly PF, et al.; LifeLines Cohort Study; EchoGen Consortium; AortaGen Consortium; CHARGE Consortium Heart Failure Working Group; KidneyGen Consortium; CKDGen Consortium; Cardiogenics Consortium; CardioGram. Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet. 2011;43:1005-1011. doi: 10.1038/ng.922.
27. Ehret GB, Caulfield MJ. Genes for blood pressure: an opportunity to understand hypertension. Eur Heart J. 2013;34:951-961. doi: 10.1093/ eurheartj/ehs455.
28. Munroe PB, Barnes MR, Caulfield MJ. Advances in blood pressure genomics. Circ Res. 2013;112:1365-1379. doi: 10.1161/ CIRCRESAHA.112.300387.
29. Salvi E, Kutalik Z, Glorioso N, et al. Genomewide association study using a high-density single nucleotide polymorphism array and case-control design identifies a novel essential hypertension susceptibility locus in the promoter region of endothelial NO synthase. Hypertension. 2012;59:248-255. doi: 10.1161/HYPERTENSIONAHA.111.181990.
30. Graham LA, Padmanabhan S, Fraser NJ, Kumar S, Bates JM, Raffi HS, Welsh P, Beattie W, Hao S, Leh S, Hultstrom M, Ferreri NR, Dominiczak AF, Graham D, McBride MW. Validation of uromodulin as a candidate gene for human essential hypertension. Hypertension. 2014;63:551-558. doi: 10.1161/HYPERTENSIONAHA.113.01423.
31. Salvi E, Kuznetsova T, Thijs L, et al. Target sequencing, cell experiments, and a population study establish endothelial nitric oxide synthase (eNOS) gene as hypertension susceptibility gene. Hypertension. 2013;62: 844-852. doi: 10.1161/HYPERTENSIONAHA.113.01428.
32. Trudu M, Janas S, Lanzani C, et al; Swiss Kidney Project on Genes in Hypertension (SKIPOGH) Team. Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression. Nat Med. 2013;19:1655-1660. doi: 10.1038/ nm.3384.
33. Arora P, Wu C, Khan AM, et al. Atrial natriuretic peptide is negatively regulated by microRNA-425. J Clin Invest. 2013;123:3378-3382. doi: 10.1172/JCI67383.
34. Takeuchi F, Isono M, Katsuya T, et al. Blood pressure and hypertension are associated with 7 loci in the Japanese population. Circulation. 2010;121:2302-2309.
35. Newton-Cheh C, Larson MG, Vasan RS, et al. Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure. Nat Genet. 2009;41:348-353.
36. Johnson AD, Newton-Cheh C, Chasman DI, et al. Association of hypertension drug target genes with blood pressure and hypertension in 86, 588 individuals. Hypertension. 2011;57:903-910.
37. Carey RM, Schoeffel CD, Gildea JJ, et al. Salt sensitivity of blood pressure is associated with polymorphisms in the sodium-bicarbonate cotransporter. Hypertension. 2012;60:1359-1366. doi: 10.1161/ HYPERTENSIONAHA.112.196071.
38. Turner ST, Boerwinkle E, O'Connell JR, et al. Genomic association analysis of common variants influencing antihypertensive response to hydrochlorothiazide. Hypertension. 2013;62:391-397.
39. McDonough CW, Burbage SE, Duarte JD, et al. Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diuretics. J Hypertens. 2013;31:698-704.
40. Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel JM. A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid- remediable aldosteronism and human hypertension. Nature. 1992;355:262-265. doi: 10.1038/355262a0.
41. Lafferty AR, Torpy DJ, Stowasser M, Taymans SE, Lin JP, Huggard P, Gordon RD, Stratakis CA. A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22). J Med Genet. 2000;37:831-835.
42. Cerame BI, New MI. Hormonal hypertension in children: 11beta-hydroxylase deficiency and apparent mineralocorticoid excess. J Pediatr Endocrinol Metab. 2000;13:1537-1547.
43. Geller DS, Farhi A, Pinkerton N, Fradley M, Moritz M, Spitzer A, Meinke G, Tsai FT, Sigler PB, Lifton RP. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science. 2000;289:119-123.
44. Rafestin-Oblin ME, Souque A, Bocchi B, Pinon G, Fagart J, Vandewalle A. The severe form of hypertension caused by the activating S810L mutation in the mineralocorticoid receptor is cortisone related. Endocrinology. 2003;144:528-533. doi: 10.1210/en.2002-220708.
45. Mansfield TA, Simon DB, Farfel Z, Bia M, Tucci JR, Lebel M, Gutkin M, Vialettes B, Christofilis MA, Kauppinen-Makelin R, Mayan H, Risch N, Lifton RP. Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11- q21. Nat Genet. 1997;16:202-205. doi: 10.1038/ng0697-202.
46. Wilson FH, Disse-Nicodème S, Choate KA, et al. Human hypertension caused by mutations in WNK kinases. Science. 2001;293:1107-1112. doi: 10.1126/science.1062844.
47. Gagnon KB, Delpire E. Molecular physiology of SPAK and OSR1: two Ste20-related protein kinases regulating ion transport. Physiol Rev. 2012;92:1577-1617. doi: 10.1152/physrev.00009.2012.
48. Richardson C, Rafiqi FH, Karlsson HK, Moleleki N, Vandewalle A, Campbell DG, Morrice NA, Alessi DR. Activation of the thiazide-sensitive Na+-Cl- cotransporter by the WNK-regulated kinases SPAK and OSR1. J Cell Sci. 2008;121:675-684. doi: 10.1242/jcs.025312.
49. Boyden LM, Choi M, Choate KA, et al. Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature. 2012;482:98-102. doi: 10.1038/nature10814.
50. Gamba G. Molecular physiology and pathophysiology of electroneutral cation-chloride cotransporters. Physiol Rev. 2005;85:423-493. doi: 10.1152/physrev.00011.2004.
51. Ohta A, Schumacher FR, Mehellou Y, Johnson C, Knebel A, Macartney TJ, Wood NT, Alessi DR, Kurz T. The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction. Biochem J. 2013;451:111-122. doi: 10.1042/BJ20121903.
52. Shibata S, Zhang J, Puthumana J, Stone KL, Lifton RP. Kelch-like 3 and Cullin 3 regulate electrolyte homeostasis via ubiquitination and degradation of WNK4. Proc Natl Acad Sci U S A. 2013;110:7838-7843. doi: 10.1073/pnas.1304592110.
53. de Los Heros P, Alessi DR, Gourlay R, Campbell DG, Deak M, Macartney TJ, Kahle KT, Zhang J. The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K+-Cl- co-transporters. Biochem J. 2014;458:559-573. doi: 10.1042/BJ20131478.
54. Louis-Dit-Picard H, Barc J, Trujillano D, et al; International Consortium for Blood Pressure (ICBP). KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron. Nat Genet. 2012;44:456-60, S1. doi: 10.1038/ng.2218.
55. Schumacher FR, Sorrell FJ, Alessi DR, Bullock AN, Kurz T. Structural and biochemical characterization of the KLHL3-WNK kinase interaction important in blood pressure regulation. Biochem J. 2014;460:237-246. doi: 10.1042/BJ20140153.
56. Andérica-Romero AC, Escobar L, Padilla-Flores T, Pedraza-Chaverri J. Insights in cullin 3/WNK4 and its relationship to blood pressure regulation and electrolyte homeostasis. Cell Signal. 2014;26:1166-1172. doi: 10.1016/j.cellsig.2014.01.032.
57. Hansson JH, Nelson-Williams C, Suzuki H, Schild L, Shimkets R, Lu Y, Canessa C, Iwasaki T, Rossier B, Lifton RP. Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome. Nat Genet. 1995;11:76-82. doi: 10.1038/ng0995-76.
58. Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, Gill JR Jr, Ulick S, Milora RV, Findling JW. Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell. 1994;79:407-414.
59. Ji W, Foo JN, O'Roak BJ, Zhao H, Larson MG, Simon DB, Newton-Cheh C, State MW, Levy D, Lifton RP. Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet. 2008;40:592-599. doi: 10.1038/ng.118.
60. Eyre-Walker A. Evolution in health and medicine Sackler colloquium: Genetic architecture of a complex trait and its implications for fitness and genome-wide association studies. Proc Natl Acad Sci U S A. 2010;107(suppl 1):1752-1756. doi: 10.1073/pnas.0906182107.
61. Pritchard JK. Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet. 2001;69:124-137. doi: 10.1086/321272.
62. Spät A. Glomerulosa cell-a unique sensor of extracellular K+ concentration. Mol Cell Endocrinol. 2004;217:23-26. doi: 10.1016/j.mce.2003.10.046.
63. Scholl UI, Lifton RP. New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5. Curr Opin Nephrol Hypertens. 2013;22:141-147. doi: 10.1097/MNH.0b013e32835cecf8.
64. Spät A, Hunyady L. Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol Rev. 2004;84:489-539. doi: 10.1152/physrev.00030.2003.
65. Brown MJ. Ins and outs of aldosterone-producing adenomas of the adrenal: from channelopathy to common curable cause of hypertension. Hypertension. 2014;63:24-26. doi: 10.1161/HYPERTENSIONAHA.113.01833.
66. Funder J, Carey R, Fardella C et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline. Eur J Endocrinol 2009.
67. Zennaro MC, Rickard AJ, Boulkroun S. Genetics of mineralocorticoid excess: an update for clinicians. Eur J Endocrinol. 2013;169:R15-R25. doi: 10.1530/EJE-12-0813.
68. Choi M, Scholl UI, Yue P, et al. K+ channel mutations in adrenal aldosterone- producing adenomas and hereditary hypertension. Science. 2011;331:768-772. doi: 10.1126/science.1198785.
69. Azizan EA, Poulsen H, Tuluc P, et al. Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nat Genet. 2013;45:1055-1060. doi: 10.1038/ng.2716.
70. Beuschlein F, Boulkroun S, Osswald A, et al. Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nat Genet. 2013;45:440-4, 444e1. doi: 10.1038/ ng.2550.
71. Scholl UI, Goh G, Stölting G, et al. Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nat Genet. 2013;45:1050-1054. doi: 10.1038/ng.2695.
72. New MI, Levine LS. Hypertension of childhood with suppressed renin. Endocr Rev. 1980;1:421-430.
73. Welander J, Söderkvist P, Gimm O. Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. Endocr Relat Cancer. 2011;18:R253-R276. doi: 10.1530/ERC-11-0170.
74. Opocher G, Schiavi F. Genetics of pheochromocytomas and paragangliomas. Best Pract Res Clin Endocrinol Metab. 2010;24:943-956. doi: 10.1016/j.beem.2010.05.001.
75. Iacobone M, Schiavi F, Bottussi M, Taschin E, Bobisse S, Fassina A, Opocher G, Favia G. Is genetic screening indicated in apparently sporadic pheochromocytomas and paragangliomas? Surgery. 2011;150:1194-1201. doi: 10.1016/j.surg.2011.09.024.
76. Albrechtsen A, Grarup N, Li Y, et al; D.E.S.I.R. Study Group; DIAGRAM Consortium. Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia. 2013;56:298-310. doi: 10.1007/s00125-012-2756-1.
77. Padmanabhan S, Graham L, Ferreri NR, Graham D, McBride M, Dominiczak AF. Uromodulin, an emerging novel pathway for blood pressure regulation and hypertension. Hypertension. 2014;64:918-923. doi: 10.1161/HYPERTENSIONAHA.114.03132.
78. O'Donoghue M, Braunwald E. Natriuretic peptides in heart failure: should therapy be guided by BNP levels? Nat Rev Cardiol. 2010;7:13-20. doi: 10.1038/nrcardio.2009.197.
79. Rademaker MT, Charles CJ, Kosoglou T, Protter AA, Espiner EA, Nicholls MG, Richards AM. Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure. Am J Physiol. 1997;273:H2372-H2379.
80. Pasquinelli AE. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet. 2012;13:271-282. doi: 10.1038/nrg3162.
81. Thomas M, Lieberman J, Lal A. Desperately seeking microRNA targets. Nat Struct Mol Biol. 2010;17:1169-1174. doi: 10.1038/nsmb.1921.
82. Guyton AC, Coleman TG, Fourcade JC, Navar LG. Physiologic control of arterial pressure. Bull N Y Acad Med. 1969;45:811-830.
83. He FJ, Li J, Macgregor GA. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ. 2013;346:f1325.
84. Kanbay M, Chen Y, Solak Y, Sanders PW. Mechanisms and consequences of salt sensitivity and dietary salt intake. Curr Opin Nephrol Hypertens. 2011;20:37-43. doi: 10.1097/MNH.0b013e32834122f1.
85. Weinberger MH, Miller JZ, Luft FC, Grim CE, Fineberg NS. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension. 1986;8:II127-II134.
86. Sanada H, Jones JE, Jose PA. Genetics of salt-sensitive hypertension. Curr Hypertens Rep. 2011;13:55-66. doi: 10.1007/s11906-010-0167-6.
87. Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature. 2009;461:747-753. doi: 10.1038/ nature08494.
88. Zuk O, Hechter E, Sunyaev SR, Lander ES. The mystery of missing heritability: Genetic interactions create phantom heritability. Proc Natl Acad Sci U S A. 2012;109:1193-1198. doi: 10.1073/pnas.1119675109.
89. Lee SH, Wray NR, Goddard ME, Visscher PM. Estimating missing heritability for disease from genome-wide association studies. Am J Hum Genet. 2011;88:294-305. doi: 10.1016/j.ajhg.2011.02.002.
90. Visscher PM, Brown MA, McCarthy MI, Yang J. Five years of GWAS discovery. Am J Hum Genet. 2012;90:7-24. doi: 10.1016/j.ajhg.2011.11.029.